Altman Michael Seth (CIK 0001746738)

Latest company ownership

Shares held
45,000
Last filed at
Jun 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 11, 2020 Aug 11, 2020 Nautilus Biotechnology, Inc. CFO Buy 100.0 +499,000 100.00% $5M